ACRO Biomedical Co., Ltd. develops and produces biomaterial medical devices for human tissue engineering and regenerative medicine. The company was founded on June 26, 2014 and is headquartered in Kaoshiung, Taiwan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company